Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Paraproteinemias 1Neoplasms, Plasma Cell 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia 1

Interventions

Cyclophosphamide 17Cytarabine 11venetoclax 9fludarabine 9Mycophenolic Acid 8Busulfan 7fludarabine phosphate 6Whole-Body Irradiation 6ruxolitinib 5Tacrolimus 5Methotrexate 5Daunorubicin 5Cyclosporine 5Azacitidine 5ponatinib 4Vincristine 4Rituximab 4Peripheral Blood Stem Cell Transplantation 4Etoposide 4Dexamethasone 4blinatumomab 3asciminib 3Prednisone 3Mercaptopurine 3Inotuzumab Ozogamicin 3Doxorubicin 3revumenib 2quizartinib 2pegfilgrastim 2pegaspargase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Clonal Hematopoiesis × 90 days × Clear all
NCT06870760 2026-04-16

Pre-malignant States to Hematologic Malignancies in Firefighters

Wake Forest University Health Sciences

Recruiting
300 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, Paraproteinemias, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡